Highly multiplexed imaging by Cyclic Immunofluorescence (CycIF) of protein levels and protein phosphorylation states in the COLO 858 melanoma cell line - Dataset (ID:20236)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit Timepoint Timepoint Unit Raw Image Registered Image CycIF Round Primary Antibody Secondary Antibody Cytell filter Protein Detected Other Reagent Detected Measured Fluorescence Intensity (a.u.) Field Cell ID Number X-coordinate Y-coordinate Cell Area (um^2) Cell Perimeter (um) Cell Circularity
COLO 858 Vemurafenib
0.316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 411.9 7
0046-0151
472.56 151.08 281 60.53 0.964
COLO 858 Vemurafenib
0.316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 373.4 7
0047-0153
408.79 153.93 304 67.94 0.828
COLO 858 Vemurafenib
0.316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 1323.5 7
0048-0155
769.28 154.23 416 77.01 0.881
COLO 858 Vemurafenib
0.316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 391.5 7
0049-0160
729.61 159.76 426 78.91 0.860
COLO 858 Vemurafenib
0.316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 1096.3 7
0050-0171
710.91 171.77 471 83.15 0.856
COLO 858 Vemurafenib
0.316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 679.8 7
0051-0176
84.38 176.01 398 74.18 0.909
COLO 858 Vemurafenib
0.316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 464.0 7
0052-0179
757.95 179.10 405 74.67 0.913
COLO 858 Vemurafenib
0.316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 642.4 7
0053-0183
829.21 183.92 409 76.18 0.886
COLO 858 Vemurafenib
0.316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 3270.7 7
0054-0182
399.69 182.76 395 74.67 0.890
COLO 858 Vemurafenib
0.316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 339.7 7
0055-0190
561.34 189.93 399 74.43 0.905
COLO 858 Vemurafenib
0.316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 1184.3 7
0056-0202
470.42 202.54 999 119.88 0.874
COLO 858 Vemurafenib
0.316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 289.4 7
0057-0196
663.68 196.18 453 79.26 0.906
COLO 858 Vemurafenib
0.316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 373.8 7
0058-0195
880.66 195.17 430 79.50 0.855
COLO 858 Vemurafenib
0.316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 334.8 7
0059-0196
922.97 196.10 429 78.67 0.871
COLO 858 Vemurafenib
0.316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 280.1 7
0060-0202
796.04 201.96 411 75.01 0.918
COLO 858 Vemurafenib
0.316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 3113.2 7
0061-0206
348.07 206.46 389 73.01 0.917
COLO 858 Vemurafenib
0.316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 451.6 7
0062-0209
516.77 208.98 444 83.01 0.810
COLO 858 Vemurafenib
0.316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 290.7 7
0063-0220
186.65 219.98 420 76.33 0.906
COLO 858 Vemurafenib
0.316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 393.7 7
0064-0229
52.67 230.01 832 116.71 0.768
COLO 858 Vemurafenib
0.316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 283.5 7
0065-0221
413.57 222.10 437 84.18 0.775
COLO 858 Vemurafenib
0.316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 440.3 7
0066-0223
154.97 223.16 415 76.67 0.887
COLO 858 Vemurafenib
0.316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 287.2 7
0067-0225
212.81 225.04 416 76.67 0.889
COLO 858 Vemurafenib
0.316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 393.1 7
0068-0236
277.65 236.50 804 114.33 0.773
COLO 858 Vemurafenib
0.316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 403.4 7
0069-0230
717.96 230.20 468 83.26 0.848
COLO 858 Vemurafenib
0.316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 401.3 7
0070-0231
512.52 230.88 408 78.18 0.839